Plastoform able to operate as going concern, company tells SGX

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

Plastoform able to operate as going concern, company tells SGX.

AUDIO-SPEAKER maker Plastoform Holdings' board said on Wednesday it believes that the company will be able to operate as a going concern and is in discussions about fundraising options, including a rights issue exercise, to obtain additional funding for working capital needs.It added that the firm will also borrow money if needed. The company also said it believes its licence business with Monster Inc will possibly lead to more product types and brands to the market in the future.

Plastoform was responding to Singapore Exchange's queries regarding its financials. It noted that the company is in a negative equity position of HK$0.89 million and has negative working capital of HK$1.35 million as at Dec 31, and has generated negative cash flow from operating activities of HK$1.87 million.It added:"The company still runs the original design manufacturing business and has also started new brand licencing sales with Monster logo with commencement in late-2018.

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 15. in RU
 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Источник: ChannelNewsAsia - 🏆 6. / 66 Прочитайте больше »

US senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Источник: ChannelNewsAsia - 🏆 6. / 66 Прочитайте больше »